-The Economic Times World Bank has said it will extend full financial support to India to help enhance the abysmal level of infrastructural development in the country in the 12th Five Year Plan that begins next fiscal. The World Bank president Robert B Zoellick, who begins his fifth and last official visit to India on Monday, has expressed intent to discuss innovative methods of financing with Indian leaders during his stay. "India's needs...
More »SEARCH RESULT
Anna Hazare sets 2014 deadline for government to convert Jan Lokpal bill into a law
-The Economic Times Anna Hazare and his team were once again on the confrontation course with the Manmohan Singh government, with the activist setting 2014 - which coincides with the next general elections - as the deadline for converting the Jan Lokpal bill, drafted by them, into a law. "Government's intention is not clear on removing corruption and that is why they are not bringing Jan Lokpal Bill," alleged Hazare while staging...
More »Bedrock for reform
-The Business Standard Agri Survey diagnoses the key problems correctly The first-ever Agricultural Survey tabled in Parliament, emulating the presentation of the Economic Survey, seems a well-meaning exercise in candid analysis of the factors that have constrained the sector’s growth. Being an inaugural report card, it has done well not to confine itself to developments during 2011-12. The long-term trends do, indeed, provide the answers to some of the key questions...
More »Education quality down on poor funds utilization-Prashant K Nanda
Poor utilization of funds and irregular disbursals have been cited as the reasons for India’s school education system failing to show desired improvement even as the government has more than doubled funds for education programmes in the past two years. The government has spent just 70% of the funds allocated for Sarva Shiksha Abhiyan (education for all) and Right to Education in 2010-11 compared with 78% in the year earlier, according...
More »India patent bypass delivers life-saving blow against cancer by Raja Murthy
India's decision this month to produce Germany-based multinational Bayer's anti-cancer drug Nexavar, in the first use of "compulsory licensing" in South Asia, will save lives but also raises intricate questions. Under the compulsory licensing process, a government can under World Trade Organization (WTO) rules bypass a patent owner's rights after three years and order the manufacture and sale of life-saving medicines at much cheaper cost than by obtaining the medicine from...
More »